Lys20

Site Information
MDKKLSLkLNGGRHV SwissProt Entrez-Gene
Blast this site against: NCBI SwissProt PDB
Site Group ID: 12306468

In vivo Characterization
Methods used to characterize site in vivo:	mass spectrometry ( 1 , 2 )
Disease tissue studied:	leukemia ( 2 )
Relevant cell line - cell type - tissue:	ES-J1 (stem) ( 1 ) , RAW 264.7 (macrophage) ( 2 )

References
1	Zhou J (2010) CST Curation Set: 9129; Year: 2010; Biosample/Treatment: cell line, ES J1/untreated; Disease: -; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: Ub(K-e-GG) Curated Info
2	Possemato A (2009) CST Curation Set: 6916; Year: 2009; Biosample/Treatment: cell line, RAW 264.7/untreated; Disease: leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: Ub(K-e-GG) Curated Info